| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |